Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Enteric diseases are intestinal infections caused by a variety of bacteria, viruses and parasites when they enter the body through the mouth or intestinal systems such as salmonella, shigella, giardia lamblia, campylobacter, cryptosporidium and vibrio cholerae causing salmonellosis, shigellosis, giardiasis, campylobacteriosis, cryptosporidiosis and cholera, respectively.

Statistics:

The global enteric disease testing market is estimated to account for US$ 4,432.7 Mn in terms of value by the end of 2027.

Global Enteric Disease Testing Market: Drivers

High incidence of cholera is expected to propel growth of the global enteric disease testing market over the forecast period. For instance, according to United Nations High Commissioner for Refugees, in 2019, torrential rains and widespread flooding across Yemen led to more than 364,000 suspected cases of cholera and 639 deaths reported since the beginning of the year.

Moreover, outbreak of enteric disease is expected to boost demand for enteric disease testing. For instance, in August 2020, a salmonella outbreak was reported in 47 states in the U.S. The Centers for Disease Control and Prevention reported the number of reported cases of salmonella newport illnesses had grown to 869 cases, with 116 hospitalizations in 47 states in the third week of August.

Statistics:

North America held dominant position in the global enteric disease testing market in 2019, accounting for 38.5% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Enteric Disease Testing Market Share (%) Value, By Region, 2019

Enteric Disease Testing  | Coherent Market Insights

Global Enteric Disease Testing Market: Restraints

Lack of awareness regarding enteric disease, especially in emerging economies, is expected to hinder growth of the global enteric disease testing market.

Moreover, most of the people infected with enteric pathogens are asymptomatic or show mild symptoms. Mild nature of diseases let people ignore its diagnosis. Although, asymptomatic or mild nature of enteric diseases is good for human being but on the other hand it is considered as one of the major restraints affecting growth of the global enteric disease testing market.

request-sample

Enteric Disease Testing Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 3,643.4 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 2.5% 2027 Value Projection: US$ 4,432.7 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Diseases Type: E. coli Infection, Salmonellosis, Campylobacteriosis, Rotavirus Infection, Cryptosporidiosis, Norovirus Infection, Cholera, C. difficile, H. pylori, Amebiasis, Shigellosis.
Companies covered:

Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech

Growth Drivers:
  • Increasing prevalence of enteric diseases
  • Approval and launch of new products
Restraints & Challenges:
  • Low awareness in developing economies

Global Enteric Disease Testing Market: Opportunities 

Development of vaccines for bovine enteric diseases is expected to offer lucrative growth opportunities for players in the global enteric disease testing market. Diarrhea in calves may be highly fatal. If scours do not respond to commercial vaccines, autogenous vaccines may help.

Moreover, R&D in enteric diseases is also expected to boost demand for enteric disease testing. For instance, The International Centre for Diarrhoeal Disease Research, Bangladesh, and Emory University of the United States conducted studies in April 2017–January 2018 and April–October 2019 and found a high concentration of pathogens such as Escherichia coli, norovirus, Vibrio cholerae, shigella, Salmonella typhi and giardia in Bangladesh.

Statistics:

The global enteric disease testing market was valued at US$ 3,643.4 Mn in 2019 and is forecast to reach a value of US$ 4,432.7 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027.

Figure 2: Global Enteric Disease Testing Market Value (US$ Mn), 2016 – 2027

Enteric Disease Testing  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2019, Mobidiag Ltd., a molecular diagnostics company, received CE marking for its Novodiag Stool Parasites test. The new test is used for the detection of intestinal parasites directly from stool samples.

Outbreak of campylobacter infection is expected to propel growth of the global enteric disease testing market. For instance, in August 2020, Lindsay Farm, New Zealand, recalled raw drinking milk in New Zealand after one person needed hospital treatment for a Campylobacter infection.

Global Enteric Disease Testing Market: Competitive Landscape

Major players operating in the global enteric disease testing market include, Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech.

Global Enteric Disease Testing Market: Key Developments

Major players in the global enteric disease testing market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2019, ERADA Technology Alliance Ltd. (ERADA) launched saliva-based diagnostic tool, Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART), for detection of parasites causing malaria.

Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five each year, and children who survive repeated infections by gut pathogens in the early years of their life may suffer from lifelong health problems. This continuous rise in enteric infections among children is one of the major factors contributing to growth of the enteric disease testing market. Moreover, increasing launch of enteric disease testing products by key manufacturers is expected assist the growth of the market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Enteric Disease Testing market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Enteric Disease Testing market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Enteric Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Enteric Disease Testing market

Detailed Segmentation:

  • Global Enteric Disease Testing Market, By Disease Type:
    • E. coli Infection
    • Salmonellosis
    • Campylobacteriosis
    • Rotavirus Infection
    • Cryptosporidiosis
    • Norovirus Infection
    • Cholera
    • C. difficile
    • H. pylori
    • Amebiasis
    • Shigellosis
  • Global Enteric Disease Testing Market, By Region:
    • North America
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type:
        • E. coli Infection
        • Salmonellosis
        • Campylobacteriosis
        • Rotavirus Infection
        • Cryptosporidiosis
        • Norovirus Infection
        • Cholera
        • C. difficile
        • H. pylori
        • Amebiasis
        • Shigellosis
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Alere, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Becton Dickinson & Company
    • Biomerica, Inc.
    • bioMerieux
    • Bio-Rad
    • Cepheid
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience, Inc.
    • Quest Diagnostics
    • Trinity Biotech
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease Type
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Enteric Disease Testing Market, By Disease Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • E. coli Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Salmonellosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Campylobacteriosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Rotavirus Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cryptosporidiosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Norovirus Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cholera
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • C. difficile
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • H. pylori
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Amebiasis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Shigellosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Enteric Disease Testing Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape
    • Company Profiles
      • Alere, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton Dickinson & Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biomerica, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • bioMerieux
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cepheid
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Coris BioConcept
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DiaSorin
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Meridian Bioscience, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Quest Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Trinity Biotech
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Enteric Disease Testing Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Enteric Disease Testing market size was valued at US$ 3,643.4 million in 2019 and is estimated to exhibit a CAGR of 2.5% between 2020 and 2027.
E. coli Infection segment held the major market share in 2019 owing to an increasing prevalence of E. coli infection in developing economies is expected to propel growth of the market
Major factor driving the growth of Global Enteric Disease Testing market during the forecast period increasing prevalence enteric dieseases, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Enteric Disease Testing market during the forecast period constitutes of low awareness in lower income economies.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Alere, Inc., Becton Dickinson & Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner